Zepzelca 4 mg lyophilized powder for injection Images
Generic Name: lurbinectedin
This medication has been identified as Zepzelca 4 mg lyophilized powder for injection. It is supplied by Jazz Pharmaceuticals plc.
Zepzelca is used in the treatment of Small Cell Lung Cancer and belongs to the drug class alkylating agents. Zepzelca 4 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Zepzelca
- Generic Name
- lurbinectedin
- Strength
- 4 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jazz Pharmaceuticals plc
- Manufacturer
- Pharma Mar, S.A.
- National Drug Code (NDC)
- 68727-0712
See also:
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Trexall
Trexall is used for acute lymphoblastic leukemia, acute lymphocytic leukemia, breast cancer ...
Atezolizumab
Atezolizumab (Tecentriq) is a type of immunotherapy drug that helps the body's immune system to ...
Etoposide
Etoposide is used for cancer, hodgkin's lymphoma, multiple myeloma, ovarian cancer, small cell lung ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
More about Zepzelca (lurbinectedin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.